AIS Healthcare Recognized by Accreditation Commission for Health Care
12 Dec 2023
DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
Formed in 1986, the Accreditation Commission for Health Care grants accreditation for providers in the home care and home infusion therapy industries. The Commission plays a critical role in ensuring providers deliver quality and effective services to patients. Accreditation also helps providers like AIS Healthcare to demonstrate their ability to meet official regulatory requirements and standards, resulting in a higher level of performance and a greater focus on patient care.
“This accomplishment is a testament to our employees who commit themselves to providing the highest quality care to our patients. We will continue to take the steps necessary to ensure every one of our employees, every process, and every protocol puts patient safety first. Thank you to ACHC for this important recognition and to the entire team at AIS Healthcare for their dedication to the patients we serve,” said Simon Castellanos, AIS Healthcare CEO.
About AIS Healthcare
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.